SEC kicker for Auburn football, and had to battle ulcerative colitis and Crohn's disease to make a heart-warming return.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

The FDA has approved a new single-injection, once-monthly maintenance regimen for Eli Lilly’s Omvoh (mirikizumab-mrkz), ...

The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). Do you or someone you love have moderate to ...

The FDA has approved a once-monthly injection of Eli Lilly’s Omvoh for maintenance therapy in adult patients with moderately ...

Ulcerative Colitis Treatment Market To Reach $12.79 Billion By 2033 Biologics, Biosimilars & Small Molecules Rise. EINPresswire/ -- According to DataM Intelligence, the ulcerative colitis treatment ...

Market Implications: This study update could positively impact Pfizer’s stock performance by demonstrating the real-world effectiveness of tofacitinib, potentially increasing investor confidence. As ...

Eli Lilly said federal regulators have approved of a single-injection, once-monthly maintenance regimen in the U.S. for its ulcerative colitis treatment Omvoh.

CESSA Phase 3 Clinical Trial Results Earn ACG Presidential Poster Distinction Among Nearly 6,000 Abstracts Next-generation Hydrocortisone Acetate (ngHCA™) Suppository Administered with Sephure® Suppos ...

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Learn about the importance of protein for ulcerative colitis, specific protein needs, and the top UC-friendly sources to support healing and minimize flares.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled A Multi-Center, Prospective, ...